HSTCOTCPharmaceutical PreparationsFiscal year ends December 31
HST Global, Inc.
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-K on Nov 3, 2025
$0.70+0.57 (+423.56%)
Close on Oct 19, 2026
- Market cap
- $28.78M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.6998 (+349,900%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
HST Global, Inc. reported revenue of $0 for the twelve months to Sep 30, 2024.
Revenue
$0
TTM Q3 2024
Operating income
-$98.12K
TTM Q3 2024
EPS, diluted
-$0.02
TTM Q3 2024
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2024
Valuation
- Market cap
- $28.78M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 23.23
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $0
- Net income
- -$101.51K
- EPS, diluted
- -$0.02
- Book value per share
- $0.03
- Diluted shares
- 41M
Fifteen years at a glance
Fiscal years 2009 to 2023 and trailing twelve months, USD
Revenue
$0
Operating income
-$98.12K
Net income
-$101.51K
EPS, diluted
-$0.02
Reported periodTrailing twelve months